Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Pseudo Biologist who wrote (16761)	3/8/1998 12:04:00 AM
From: Henry Niman	Respond to of 32384

PB, I don't have all of the details. The Keystone meeting was last month. I think that the Lake Tahoe meeting just happened. I think that LGND may have revealed the structure and it is about 500 daltons. The molecule described at the meeting was for G-CSF and I think that it was specific for the mouse G-CSF. However, I believe that DR suggested that SBH may file an IND this year, so I suspect that the human version is well on its way, but Ligand is NOT talking about it. I also suspect that many of the 200 pending patents are in this area. LGND has a screening procedure. They have a prototype that works. I strongly suspect that the screening protocol is widely applicable and LGND has been using it for awhile. They have screened many big pharma's libraries. I'm not sure what was screen for what and with what, but I would say that the me toos are now everywhere.